Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)

NCT02959489 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

315

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Amyloid Beta-Peptides
Risk Assessment
Education
Neuropsychological Tests
Neuroimaging

Interventions

BEHAVIORAL: Alzheimer's Disease Risk Disclosure
BEHAVIORAL: Amyloid Brain Imaging and Alzheimer's Disease Risk Disclosure

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]